1. Market Research
  2. > Healthcare Market Trends
  3. > Intra Ocular Lens (IOL) - Medical Devices Pipeline Assessment, 2015

Intra Ocular Lens (IOL) - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, “Intra Ocular Lens (IOL) - Medical Devices Pipeline Assessment, 2015" provides an overview of Intra Ocular Lens (IOL) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Intra Ocular Lens (IOL) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Intra Ocular Lens (IOL) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Intra Ocular Lens (IOL) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Intra Ocular Lens (IOL) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Intra Ocular Lens (IOL) - Medical Devices Pipeline Assessment, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Figures 4
1.2 List of Figures 15
2 Introduction 16
2.1 Intra Ocular Lens (IOL) Overview 16
3 Products under Development 17
3.1 Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development 17
3.2 Intra Ocular Lens (IOL) - Pipeline Products by Segment 18
3.3 Intra Ocular Lens (IOL) - Pipeline Products by Territory 19
3.4 Intra Ocular Lens (IOL) - Pipeline Products by Regulatory Path 20
3.5 Intra Ocular Lens (IOL) - Pipeline Products by Estimated Approval Date 21
3.6 Intra Ocular Lens (IOL) - Ongoing Clinical Trials 22
4 Intra Ocular Lens (IOL) - Pipeline Products under Development by Companies 23
4.1 Intra Ocular Lens (IOL) Companies - Pipeline Products by Stage of Development 23
4.2 Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development 25
5 Intra Ocular Lens (IOL) Companies and Product Overview 31
5.1 Abbott Medical Optics, Inc. Company Overview 31
5.1.1 Abbott Medical Optics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 31
5.2 Adoptics AG Company Overview 37
5.2.1 Adoptics AG Pipeline Products and Ongoing Clinical Trials Overview 37
5.3 AkkoLens International BV Company Overview 38
5.3.1 AkkoLens International BV Pipeline Products and Ongoing Clinical Trials Overview 38
5.4 Alcon, Inc. Company Overview 39
5.4.1 Alcon, Inc. Pipeline Products and Ongoing Clinical Trials Overview 39
5.5 Anew Optics, Inc. Company Overview 54
5.5.1 Anew Optics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 54
5.6 Bausch and Lomb Incorporated Company Overview 55
5.6.1 Bausch and Lomb Incorporated Pipeline Products and Ongoing Clinical Trials Overview 55
5.7 Calhoun Vision, Inc. Company Overview 56
5.7.1 Calhoun Vision, Inc. Pipeline Products and Ongoing Clinical Trials Overview 56
5.8 Elenza, Inc. Company Overview 58
5.8.1 Elenza, Inc. Pipeline Products and Ongoing Clinical Trials Overview 58
5.9 Eye4Vision Ophthalmics International Company Overview 59
5.9.1 Eye4Vision Ophthalmics International Pipeline Products and Ongoing Clinical Trials Overview 59
5.10 EyeKon Medical, Inc. Company Overview 61
5.10.1 EyeKon Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 61
5.11 Hoya Surgical Optics, Inc. Company Overview 166
5.11.1 Hoya Surgical Optics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 166
5.12 HumanOptics AG Company Overview 167
5.12.1 HumanOptics AG Pipeline Products and Ongoing Clinical Trials Overview 167
5.13 Imperial Medical Technologies, Inc Company Overview 169
5.13.1 Imperial Medical Technologies, Inc Pipeline Products and Ongoing Clinical Trials Overview 169
5.14 InnFocus LLC Company Overview 174
5.14.1 InnFocus LLC Pipeline Products and Ongoing Clinical Trials Overview 174
5.15 Innovia LLC Company Overview 175
5.15.1 Innovia LLC Pipeline Products and Ongoing Clinical Trials Overview 175
5.16 LensGen, Inc. Company Overview 176
5.16.1 LensGen, Inc. Pipeline Products and Ongoing Clinical Trials Overview 176
5.17 Lenstec, Inc. Company Overview 177
5.17.1 Lenstec, Inc. Pipeline Products and Ongoing Clinical Trials Overview 177
5.18 London Eye Hospital Pharma Company Overview 178
5.18.1 London Eye Hospital Pharma Pipeline Products and Ongoing Clinical Trials Overview 178
5.19 Massachusetts Institute of Technology Company Overview 179
5.19.1 Massachusetts Institute of Technology Pipeline Products and Ongoing Clinical Trials Overview 179
5.20 Meir Medical Center Company Overview 180
5.20.1 Meir Medical Center Pipeline Products and Ongoing Clinical Trials Overview 180
5.21 Morcher Gmbh Company Overview 181
5.21.1 Morcher Gmbh Pipeline Products and Ongoing Clinical Trials Overview 181
5.22 NuLens Ltd. Company Overview 216
5.22.1 NuLens Ltd. Pipeline Products and Ongoing Clinical Trials Overview 216
5.23 Oculentis GmbH Company Overview 218
5.23.1 Oculentis GmbH Pipeline Products and Ongoing Clinical Trials Overview 218
5.24 PowerVision, Inc. Company Overview 220
5.24.1 PowerVision, Inc. Pipeline Products and Ongoing Clinical Trials Overview 220
5.25 Presbeasy Company Overview 225
5.25.1 Presbeasy Pipeline Products and Ongoing Clinical Trials Overview 225
5.26 Rayner Intraocular Lenses Limited Company Overview 226
5.26.1 Rayner Intraocular Lenses Limited Pipeline Products and Ongoing Clinical Trials Overview 226
5.27 Sharklet Technologies, Inc. Company Overview 246
5.27.1 Sharklet Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 246
5.28 STAAR Surgical Company Company Overview 247
5.28.1 STAAR Surgical Company Pipeline Products and Ongoing Clinical Trials Overview 247
5.29 TEKIA, Inc. Company Overview 254
5.29.1 TEKIA, Inc. Pipeline Products and Ongoing Clinical Trials Overview 254
5.30 University of Rochester Company Overview 260
5.30.1 University of Rochester Pipeline Products and Ongoing Clinical Trials Overview 260
5.31 University of Tampere Company Overview 261
5.31.1 University of Tampere Pipeline Products and Ongoing Clinical Trials Overview 261
5.32 Visioneering Technologies, Inc. Company Overview 262
5.32.1 Visioneering Technologies, Inc. Pipeline Products and Ongoing Clinical Trials Overview 262
5.33 Washington University in St. Louis Company Overview 263
5.33.1 Washington University in St. Louis Pipeline Products and Ongoing Clinical Trials Overview 263
5.34 Xend Company Overview 264
5.34.1 Xend Pipeline Products and Ongoing Clinical Trials Overview 264
5.35 Z Lens LLC Company Overview 265
5.35.1 Z Lens LLC Pipeline Products and Ongoing Clinical Trials Overview 265
6 Intra Ocular Lens (IOL)- Recent Developments 266
7 Appendix 289
7.1 Methodology 289
7.2 About GlobalData 291
7.3 Contact Us 292
7.4 Disclaimer 292

1.1 List of Figures
Table 1: Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development 17
Table 2: Intra Ocular Lens (IOL) - Pipeline Products by Segment 18
Table 3: Intra Ocular Lens (IOL) - Pipeline Products by Territory 19
Table 4: Intra Ocular Lens (IOL) - Pipeline Products by Regulatory Path 20
Table 5: Intra Ocular Lens (IOL) - Pipeline Products by Estimated Approval Date 21
Table 6: Intra Ocular Lens (IOL) - Ongoing Clinical Trials 22
Table 7: Intra Ocular Lens (IOL) Companies - Pipeline Products by Stage of Development 23
Table 8: Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development 25
Table 9: Abbott Medical Optics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 31
Table 10: Intraocular Lens - Astigmatism - Product Status 32
Table 11: Intraocular Lens - Astigmatism - Product Description 32
Table 12: Intraocular Lens - Presbyopia - Product Status 33
Table 13: Intraocular Lens - Presbyopia - Product Description 33
Table 14: Modified Light Transmission IOL - Product Status 34
Table 15: Modified Light Transmission IOL - Product Description 34
Table 16: Synchrony Dual Optic Accommodating IOL - Enhanced Version - Product Status 35
Table 17: Synchrony Dual Optic Accommodating IOL - Enhanced Version - Product Description 35
Table 18: TECNIS-1 Monofocal IOL - Product Status 36
Table 19: TECNIS-1 Monofocal IOL - Product Description 36
Table 20: Adoptics AG Pipeline Products and Ongoing Clinical Trials Overview 37
Table 21: Shape-Changing Accommodating Intraocular Lens - Product Status 37
Table 22: Shape-Changing Accommodating Intraocular Lens - Product Description 37
Table 23: AkkoLens International BV Pipeline Products and Ongoing Clinical Trials Overview 38
Table 24: AkkoLens AIOL - Product Status 38
Table 25: AkkoLens AIOL - Product Description 38
Table 26: Alcon, Inc. Pipeline Products and Ongoing Clinical Trials Overview 39
Table 27: Accommodative Intraocular Lens - Product Status 40
Table 28: Accommodative Intraocular Lens - Product Description 40
Table 29: AcrySof Cachet Angle-Supported Phakic Lens - Product Status 41
Table 30: AcrySof Cachet Angle-Supported Phakic Lens - Product Description 41
Table 31: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Status 42
Table 32: Acrysof IQ Restor +8 Multifocal Intraocular Lens - Product Description 42
Table 33: AcrySof IQ ReSTOR 3.0D Toric IOL - Product Status 43
Table 34: AcrySof IQ ReSTOR 3.0D Toric IOL - Product Description 43
Table 35: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Status 44
Table 36: AcrySof IQ ReSTOR 3.0D Toric IOL Diopter Range Expansion - Product Description 44
Table 37: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Status 45
Table 38: AcrySof IQ ReSTOR Distant Dominant 2.5D - Product Description 45
Table 39: AcrySof IQ ReSTOR Multifocal Toric Lens - Product Status 46
Table 40: AcrySof IQ ReSTOR Multifocal Toric Lens - Product Description 46
Table 41: AcrySof IQ ReSTOR Toric IOL 2.5D - Product Status 47
Table 42: AcrySof IQ ReSTOR Toric IOL 2.5D - Product Description 47
Table 43: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Status 48
Table 44: AcrySof IQ ReSTOR Toric IOL Diopter Range Expansion - Product Description 48
Table 45: AcrySof IQ Toric Diopter Range Expansion - Product Status 49
Table 46: AcrySof IQ Toric Diopter Range Expansion - Product Description 49
Table 47: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Status 50
Table 48: AcrySof IQ Toric IOL Low Diopter Range Expansion - Product Description 50
Table 49: Intrepid IOL - Product Status 51
Table 50: Intrepid IOL - Product Description 51
Table 51: Alcon, Inc. - Ongoing Clinical Trials Overview 52
Table 52: AcrySof IQ ReSTOR Multifocal Toric Lens - Evaluation of the Visual Acuity After the Implantation of a ReSTOR +2.5 Diopters Intraocular Lens (ReSTOR SV25T0) in the Distance Dominant Eye, in Combination With a +3.0 Diopters ReSTOR Intraocular Lens (ReSTOR SN6AD1) in the Fellow Eye 53
Table 53: Anew Optics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 54
Table 54: Zephyr Lens - Product Status 54
Table 55: Zephyr Lens - Product Description 54
Table 56: Bausch and Lomb Incorporated Pipeline Products and Ongoing Clinical Trials Overview 55
Table 57: Sarfarazi Elliptical Accommodating IOL - Product Status 55
Table 58: Sarfarazi Elliptical Accommodating IOL - Product Description 55
Table 59: Calhoun Vision, Inc. Pipeline Products and Ongoing Clinical Trials Overview 56
Table 60: Light Adjustable Lens - Product Status 57
Table 61: Light Adjustable Lens - Product Description 57
Table 62: Elenza, Inc. Pipeline Products and Ongoing Clinical Trials Overview 58
Table 63: Sapphire Autofocal IOL - Product Status 58
Table 64: Sapphire Autofocal IOL - Product Description 58
Table 65: Eye4Vision Ophthalmics International Pipeline Products and Ongoing Clinical Trials Overview 59
Table 66: HYDROPHOBICx - Product Status 60
Table 67: HYDROPHOBICx - Product Description 60
Table 68: EyeKon Medical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 61
Table 69: ACUITY FA55A-4NY IOL - Product Status 64
Table 70: ACUITY FA55A-4NY IOL - Product Description 64
Table 71: Acuity FA55A-4UV IOL - Product Status 65
Table 72: Acuity FA55A-4UV IOL - Product Description 65
Table 73: Acuity FB25B - UV IOL - Product Status 66
Table 74: Acuity FB25B - UV IOL - Product Description 66
Table 75: Acuity FB25B-NY IOL - Product Status 67
Table 76: Acuity FB25B-NY IOL - Product Description 67
Table 77: Acuity FS25B-NY IOL - Product Status 68
Table 78: Acuity FS25B-NY IOL - Product Description 68
Table 79: Acuity FS25B-UV IOL - Product Status 69
Table 80: Acuity FS25B-UV IOL - Product Description 69
Table 81: Acuity FS60S - 4NY IOL - Product Status 70
Table 82: Acuity FS60S - 4NY IOL - Product Description 70
Table 83: Acuity FS60S - 4UV IOL - Product Status 71
Table 84: Acuity FS60S - 4UV IOL - Product Description 71
Table 85: Acuity SB25B IOL - Product Status 72
Table 86: Acuity SB25B IOL - Product Description 72
Table 87: Acuity SB25B-NY IOL - Product Status 73
Table 88: Acuity SB25B-NY IOL - Product Description 73
Table 89: Acuity TN60 - 2NY IOL - Product Status 74
Table 90: Acuity TN60 - 2NY IOL - Product Description 74
Table 91: Acuity TN60-OUV IOL - Product Status 75
Table 92: Acuity TN60-OUV IOL - Product Description 75
Table 93: Acuity UB60-0UV IOL - Product Status 76
Table 94: Acuity UB60-0UV IOL - Product Description 76
Table 95: Acuity UY60 - OUV IOL - Product Status 77
Table 96: Acuity UY60 - OUV IOL - Product Description 77
Table 97: Acurus AA55A-41 IOL - Product Status 78
Table 98: Acurus AA55A-41 IOL - Product Description 78
Table 99: Acurus AA55A-44 IOL - Product Status 79
Table 100: Acurus AA55A-44 IOL - Product Description 79
Table 101: Acurus AB25B IOL - Product Status 80
Table 102: Acurus AB25B IOL - Product Description 80
Table 103: Acurus AB25BNY IOL - Product Status 81
Table 104: Acurus AB25BNY IOL - Product Description 81
Table 105: Acurus AB60 - OUV IOL - Product Status 82
Table 106: Acurus AB60 - OUV IOL - Product Description 82
Table 107: ACURUS AR60S-4 IOL - Product Status 83
Table 108: ACURUS AR60S-4 IOL - Product Description 83
Table 109: Acurus AY60 - OUV IOL - Product Status 84
Table 110: Acurus AY60 - OUV IOL - Product Description 84
Table 111: Acurus SB25B - NY IOL - Product Status 85
Table 112: Acurus SB25B - NY IOL - Product Description 85
Table 113: Acurus SB25B IOL - Product Status 86
Table 114: Acurus SB25B IOL - Product Description 86
Table 115: ACURUS UN60-2NY IOL - Product Status 87
Table 116: ACURUS UN60-2NY IOL - Product Description 87
Table 117: ACURUS UN60-OUV IOL - Product Status 88
Table 118: ACURUS UN60-OUV IOL - Product Description 88

1.2 List of Figures
Figure 1: Intra Ocular Lens (IOL) - Pipeline Products by Stage of Development 17
Figure 2: Intra Ocular Lens (IOL) - Pipeline Products by Segment 18
Figure 3: Intra Ocular Lens (IOL) - Pipeline Products by Territory 19
Figure 4: Intra Ocular Lens (IOL) - Pipeline Products by Regulatory Path 20
Figure 5: Intra Ocular Lens (IOL) - Pipeline Products by Estimated Approval Date 21
Figure 6: Intra Ocular Lens (IOL) - Ongoing Clinical Trials 22

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the ...

Ophthalmic Lasers Market by Product Type, Application, & End User - Global Forecast to 2021

Ophthalmic Lasers Market by Product Type, Application, & End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The ophthalmic lasers market is projected to reach USD 1,245.4 million by 2021 from USD 970.2 million in 2016, at a CAGR of 5.1%. Increasing prevalence of ophthalmic disorders, increasing prevalence of ...

Epiomic Epidemiology Series: Dry Eye Syndrome Forecast in 14 Major Markets 2016-2026

Epiomic Epidemiology Series: Dry Eye Syndrome Forecast in 14 Major Markets 2016-2026

  • $ 5112
  • Industry report
  • August 2016
  • by Black Swan Analysis Ltd132

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Dry Eye Syndrome in 14 Major Markets Dry Eye Syndrome (DES), also known as Keratoconjunctivitis sicca, is a multi-factorial disorde ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.